WhatsApp-based Psycho-socio-educational Intervention (WeLove) for Prevention of Psychological and Sleep Problems in Pregnant Women and Their Partners: A Three-arm Double-blinded Pilot Randomised Controlled Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChinese University of Hong Kong

About this trial

Objectives: (1) evaluate the feasibility and acceptability of the WhatsApp-based psycho-socio-educational intervention (WeLove); (2) preliminarily examine the effects of the intervention on psychological symptoms (depression, anxiety, stress symptoms), sleep quality, and life satisfaction; and (3) preliminarily examine the interdependence between psychological symptoms and sleep quality in pregnant women and their partners.

Methods: The investigators will use WhatsApp to provide the six sessions of the intervention, which include psychological, social, and educational components. A three-arm double-blinded pilot randomised controlled trial (RCT) is used in 60 couples, followed by individual face-to-face interviews for process evaluation in 10 to 20 couples based on data saturation. Participants will be assigned to one of three groups and 20 couples per group: intervention 1 (couples for WeLove), intervention 2 (pregnant women for WeLove), or the control group (use WhatsApp as normal). Participants will be assessed pre- and post-intervention. Generalised estimating equation analysis and thematic analysis will be performed to examine the research objectives.

Eligibility criteria

Qualifiers

pregnant with a gestation of >12 to 28 weeks and their partners over 18 years

able to read and understand Chinese

have electronic devices with WhatsApp that can contact the Internet

can provide written consent and voluntary participation in this study

Disqualifiers

current severe medical illnesses

psychological and sleep disorders

Trial design

Treatments tested in this trial

  • WhatsApp as usual
  • WhatsApp-based psycho-socio-educational intervention (WeLove)

Treatment groups

120 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Chinese University of Hong Kong

Lead sponsor

Hospital Authority, Hong Kong

Collaborator